Cardiovascular Drugs Practice Questions

Q: What is the mechanism of action of Nitric oxide?

cGMP. **Mechanism of Action of Nitric Oxide (NO)** **Explanation of the Correct Answer (A):** Nitric Oxide (NO) is a potent endogenous vasodilator and a gaseous signaling molecule. It acts via the **cGMP (cyclic Guanosine Monophosphate) pathway**. 1. NO is released from vascular endothelial cells and diffuses into adjacent smooth muscle cells. 2. It activates the enzyme **soluble Guanylyl Cyclase (sGC)**. 3. This enzyme converts GTP into **cGMP**. 4. Increased cGMP activates Protein Kinase G (PKG), leading to dephosphorylation of myosin light chains and sequestration of intracellular calcium, resulting in **smooth muscle relaxation (vasodilation)**. **Why Other Options are Incorrect:** * **B. cAMP:** This is the second messenger for drugs like Beta-agonists (e.g., Salbutamol) and Prostacyclin ($PGI_2$). While it also causes vasodilation, it is not the primary pathway for NO. * **C. Ca++:** Nitric oxide actually works by *decreasing* intracellular calcium levels to cause relaxation. Increased calcium is typically associated with muscle contraction. * **D. Tyrosine:** This refers to Tyrosine Kinase receptors, which are utilized by insulin and various growth factors, not by gaseous signaling molecules like NO. **High-Yield Clinical Pearls for NEET-PG:** * **Nitrates (Nitroglycerin):** Act as prodrugs that are metabolized to release NO, utilizing this same cGMP pathway to relieve angina. * **PDE-5 Inhibitors (Sildenafil):** These drugs inhibit the breakdown of cGMP. Since NO increases cGMP, Sildenafil potentiates NO-mediated vasodilation (used in Erectile Dysfunction and Pulmonary Hypertension). * **Inhaled NO:** Used clinically in the management of Persistent Pulmonary Hypertension of the Newborn (PPHN). * **EDRF:** Nitric Oxide was formerly known as Endothelium-Derived Relaxing Factor.

Q: Nesiritide is broken down by which enzyme?

Endopeptidase. **Explanation:** **Nesiritide** is a recombinant form of human **B-type Natriuretic Peptide (BNP)**. It is used in the management of acutely decompensated heart failure to reduce pulmonary capillary wedge pressure and improve dyspnea through its potent vasodilatory and natriuretic effects. 1. **Why Endopeptidase is correct:** Nesiritide, being a peptide, is primarily cleared from the circulation via two mechanisms: binding to natriuretic peptide receptors (NPR-C) followed by cellular internalization, and enzymatic degradation. The specific enzyme responsible for its proteolytic cleavage is **Neutral Endopeptidase (NEP)**, also known as **Neprilysin**. This enzyme breaks the peptide bonds of various endogenous vasoactive peptides, including BNP, ANP, and bradykinin. 2. **Why the other options are incorrect:** * **Angiotensin-converting enzyme (ACE):** While ACE is a peptidyl dipeptidase, its primary role is converting Angiotensin I to Angiotensin II and inactivating bradykinin. It does not play a significant role in the metabolism of BNP. * **Vasopeptidase:** This is not a single enzyme but a class of drugs (e.g., Omapatrilat) that inhibits both ACE and Neutral Endopeptidase. * **Amidase:** These enzymes catalyze the hydrolysis of an amide or peptide bond but are typically associated with the metabolism of drugs like lidocaine or certain prodrugs, not the physiological degradation of natriuretic peptides. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Nesiritide increases intracellular **cGMP**, leading to smooth muscle relaxation. * **Clinical Use:** Used in **Acute Decompensated Heart Failure (ADHF)** with dyspnea at rest. * **Major Side Effect:** Dose-related **hypotension** is the most common adverse effect. * **Related Drug:** **Sacubitril** is a Neprilysin inhibitor used in HFrEF (combined with Valsartan as ARNI) to prevent the breakdown of endogenous BNP.

Q: Sildenafil, a phosphodiesterase-5 inhibitor, can be used for which of the following conditions?

Pulmonary hypertension. **Explanation:** **Sildenafil** is a potent and selective inhibitor of **Phosphodiesterase-5 (PDE-5)**. In the lungs, PDE-5 is responsible for the degradation of cyclic Guanosine Monophosphate (cGMP) [1]. By inhibiting this enzyme, Sildenafil increases cGMP levels, which leads to smooth muscle relaxation and potent **vasodilation of the pulmonary vascular bed** [1], [2]. This reduces pulmonary artery pressure and improves exercise capacity, making it a first-line oral therapy for **Pulmonary Arterial Hypertension (PAH)** [1]. **Analysis of Incorrect Options:** * **B & C (Essential and Malignant Hypertension):** Sildenafil causes systemic vasodilation, but its effect on systemic blood pressure is relatively modest compared to its effect on the pulmonary vasculature. It is not indicated for the management of systemic hypertension or hypertensive emergencies (Malignant HTN), where drugs like ACE inhibitors, CCBs, or Sodium Nitroprusside are preferred. * **D (Hypertension in Pregnancy):** The drugs of choice for hypertension in pregnancy (Preeclampsia/Gestational HTN) are **Labetalol (DOC)**, Methyldopa, or Hydralazine. Sildenafil is not standard therapy for this condition. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Increases cGMP $\rightarrow$ Nitric Oxide (NO) mediated vasodilation [1], [2]. * **Other Indications:** Erectile Dysfunction (original use) [3], [4]. * **Contraindication:** Must **NEVER** be co-administered with **Nitrates** (e.g., Nitroglycerin) as it can cause life-threatening hypotension due to synergistic increases in cGMP. * **Side Effects:** Blue-tinted vision (Cyanopsia) due to cross-inhibition of PDE-6 in the retina, headache, and flushing. * **Tadalafil:** Another PDE-5 inhibitor used for PAH with a longer half-life than Sildenafil [1].

Q: Digoxin induced arrhythmias are treated by all the following except?

Quinidine. **Explanation:** **Quinidine (Option D)** is the correct answer because it is strictly **contraindicated** in digoxin toxicity. Quinidine increases plasma digoxin levels by displacing it from tissue binding sites and reducing its renal clearance. Furthermore, both drugs can cause additive depression of the AV node, potentially worsening heart block. **Why other options are used:** * **Lidocaine (Option A):** This is the drug of choice for digoxin-induced ventricular arrhythmias (PVCs, ventricular tachycardia). It suppresses ventricular automaticity without significantly affecting AV conduction. * **Phenytoin (Option B):** Specifically useful for digoxin-induced atrial tachyarrhythmias with AV block. It suppresses abnormal automaticity while simultaneously improving AV conduction. * **Atropine (Option C):** Used to treat digoxin-induced symptomatic bradycardia or high-grade AV block by blocking the excessive vagal (parasympathetic) tone caused by digitalis. **Clinical Pearls for NEET-PG:** 1. **Most common arrhythmia:** Ventricular Bigeminy (PVCs). 2. **Most characteristic arrhythmia:** Atrial Tachycardia with variable AV block. 3. **Electrolyte imbalances:** Hypokalemia, hypomagnesemia, and hypercalcemia predispose to toxicity. However, **Hyperkalemia** is a marker of severe acute toxicity (due to Na+/K+ ATPase inhibition). 4. **Specific Antidote:** Digoxin Immune Fab (Digibind) is the definitive treatment for life-threatening toxicity. 5. **Drugs increasing Digoxin levels:** Quinidine, Verapamil, Amiodarone, and Erythromycin.

Q: In left ventricular failure (LVF), which of the following drugs can be administered?

Morphine. **Explanation:** In Acute Left Ventricular Failure (LVF) leading to pulmonary edema, **Morphine** is a drug of choice due to its multi-modal therapeutic effects: 1. **Venodilation:** It increases venous capacitance (pooling of blood), which reduces **preload** and decreases pulmonary congestion. 2. **Anxiolysis:** It relieves the intense anxiety and "air hunger" associated with dyspnea, reducing sympathetic overactivity. 3. **Afterload Reduction:** At high doses, it causes mild arterial dilation, reducing the workload on the failing heart. **Analysis of Incorrect Options:** * **Propranolol:** A non-selective beta-blocker. It is **contraindicated** in acute LVF because it has negative inotropic effects, which can further depress cardiac output and worsen heart failure. * **Amlodipine:** A dihydropyridine calcium channel blocker. While it reduces afterload, it has no role in the acute management of LVF and may cause reflex tachycardia, increasing myocardial oxygen demand. * **Epinephrine:** A potent sympathomimetic. While it increases contractility, it significantly increases heart rate and myocardial oxygen consumption, which can worsen ischemia and trigger arrhythmias in a failing heart. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Acute Pulmonary Edema:** **LMNOP** (Loop diuretics/Furosemide, Morphine, Nitrates, Oxygen, Position/Posturing). * **Morphine Caution:** While beneficial, it must be used cautiously in patients with COPD or respiratory depression. * **Specific Antidote:** If morphine causes respiratory depression, **Naloxone** is the competitive antagonist used for reversal.

Q: A drug effect that is produced by therapeutic doses of both timolol and amiodarone is blockade of:

Beta adrenoceptors. **Explanation:** The correct answer is **C. Beta adrenoceptors**. **Mechanism and Concept:** * **Timolol** is a potent, non-selective **Beta-blocker** (Class II antiarrhythmic). Its primary mechanism of action is the competitive antagonism of $\beta_1$ and $\beta_2$ adrenoceptors. * **Amiodarone** is a unique **Class III antiarrhythmic** drug with a broad spectrum of activity. While its primary effect is blocking cardiac $K^+$ channels (prolonging action potential duration), it also possesses significant **non-competitive beta-blocking activity** (Class II effect), as well as $Na^+$ channel (Class I) and $Ca^{2+}$ channel (Class IV) blocking properties. Therefore, both drugs share the common effect of beta-adrenoceptor blockade at therapeutic doses. **Analysis of Incorrect Options:** * **A. Cardiac $Na^+$ channels:** While Amiodarone has some $Na^+$ channel blocking activity (Class I effect), Timolol does not possess membrane-stabilizing activity (MSA) or $Na^+$ channel blocking properties at therapeutic doses. * **B. Cardiac $K^+$ channels:** This is the hallmark of Class III agents like Amiodarone. Timolol, a pure beta-blocker, does not block $K^+$ channels. * **D. Alpha-adrenoceptors:** Amiodarone has mild $\alpha$-blocking activity (contributing to vasodilation), but Timolol is a pure beta-antagonist and does not block alpha-receptors. **NEET-PG High-Yield Pearls:** * **Amiodarone** is the "broad-spectrum" antiarrhythmic because it exhibits actions of all four Vaughan-Williams classes. * **Timolol** is frequently used topically in glaucoma to decrease aqueous humor production but can cause systemic side effects (like bronchospasm or bradycardia) due to systemic absorption. * **Side effect profile of Amiodarone:** Remember the "6 Ps": **P**ulmonary fibrosis, **P**hotodermatitis (Blue-grey skin), **P**eripheral neuropathy, **P**rolonged QT, and **P**roblems with Thyroid (Hypo/Hyper) and Liver (**P**arenchyma).

Q: Which of the following drugs acts as a Rho kinase inhibitor?

Fasudil. **Explanation:** **Fasudil** is the correct answer as it is a potent and selective **Rho-kinase (ROCK) inhibitor**. Rho-kinase is an enzyme that plays a critical role in vascular smooth muscle contraction by inhibiting myosin light chain phosphatase. By inhibiting ROCK, Fasudil promotes vasodilation and reduces vascular resistance. Clinically, it is primarily used in the management of **cerebral vasospasm** following subarachnoid hemorrhage and is being investigated for pulmonary hypertension. **Analysis of Incorrect Options:** * **A. Trimetazidine:** This is a **p-FOX inhibitor** (partial fatty acid oxidation inhibitor). It shifts myocardial metabolism from fatty acid oxidation to glucose oxidation, which requires less oxygen, thereby protecting cardiomyocytes during ischemia. * **C. Pinacidil:** This drug belongs to the class of **K+ATP channel openers**. By opening potassium channels, it causes hyperpolarization of smooth muscle cells, leading to peripheral vasodilation. It is used as an antihypertensive. * **D. Ranolazine:** This is a **late sodium channel blocker** ($I_{Na}$ inhibitor). It prevents calcium overload in ischemic cardiac myocytes, improving myocardial relaxation and reducing anginal pain without significantly affecting heart rate or blood pressure. **High-Yield Pearls for NEET-PG:** * **Fasudil** is unique because it targets the "calcium sensitization" pathway rather than direct calcium channel blockade. * **Trimetazidine and Ranolazine** are classified as "Metabolic Modulators" or "Add-on therapies" for chronic stable angina. * **Nicorandil** is a dual-action drug: it acts as both a K+ATP channel opener and a nitrate-like vasodilator.

Q: What is the drug of choice for hypertensive emergency?

Intravenous Nicardipine. **Explanation:** In a **hypertensive emergency** (defined as BP >180/120 mmHg with evidence of acute end-organ damage), the goal is a rapid but controlled reduction of blood pressure using parenteral agents with predictable pharmacokinetics. **Why Nicardipine is the Correct Answer:** Intravenous **Nicardipine**, a second-generation dihydropyridine calcium channel blocker (CCB), is currently considered a first-line drug of choice for most hypertensive emergencies. It is highly effective, has a rapid onset (5–15 minutes), and is easily titratable. Unlike other agents, it does not cause reflex tachycardia and has been shown to be safe in various scenarios, including neurological emergencies (stroke) and perioperative hypertension. **Analysis of Incorrect Options:** * **Clevidipine (Option A):** While also a dihydropyridine CCB used in emergencies, it is ultra-short-acting and formulated in a lipid emulsion. While effective, Nicardipine remains the more established and frequently cited "standard" in many clinical guidelines and exam patterns. * **Diltiazem and Verapamil (Options C & D):** These are non-dihydropyridine CCBs. They have significant **negative inotropic and chronotropic effects**, which can lead to heart failure or severe bradycardia. They are primarily used for rate control in arrhythmias (like AFib), not for the rapid reduction of blood pressure in emergencies. **High-Yield NEET-PG Pearls:** * **Labetalol** is the other major first-line agent, especially preferred in **Aortic Dissection** and **Preeclampsia/Eclampsia**. * **Sodium Nitroprusside**, once the gold standard, is now a second-line agent due to the risk of **cyanide/thiocyanate toxicity**. * **Fenoldopam** (D1 agonist) is the drug of choice in hypertensive emergencies with **renal impairment**. * **Esmolol** is the drug of choice for intraoperative hypertension.

Question 1

What is the mechanism of action of Nitric oxide?

Accepted Answer

cGMP

Answer

cAMP

Answer

Ca++

Answer

Tyrosine

Question 2

Nesiritide is broken down by which enzyme?

Accepted Answer

Endopeptidase

Answer

Angiotensin converting enzyme

Answer

Vasopeptidase

Answer

Amidase

Question 3

Which of the following drugs is capable of maintaining blood levels for 24 hours after a single administration but has useful antianginal effects lasting only about 10 hours?

Accepted Answer

Nitroglycerine (transdermal)

Answer

Amyl nitrite

Answer

Isosorbide mononitrate

Answer

Nitroglycerine (sublingual)

Question 4

Sildenafil, a phosphodiesterase-5 inhibitor, can be used for which of the following conditions?

Accepted Answer

Pulmonary hypertension

Answer

Essential hypertension

Answer

Malignant hypertension

Answer

Hypertension in pregnancy

Question 5

What is the primary role of nitrates in congestive cardiac failure?

Accepted Answer

Decrease preload

Answer

Direct inotropic action

Answer

Decrease afterload

Answer

Coronary vasodilatation

Question 6

Digoxin induced arrhythmias are treated by all the following except?

Accepted Answer

Quinidine

Answer

Lidocaine

Answer

Phenytoin

Answer

Atropine

Question 7

In left ventricular failure (LVF), which of the following drugs can be administered?

Accepted Answer

Morphine

Answer

Propranolol

Answer

Amlodipine

Answer

Epinephrine

Question 8

A drug effect that is produced by therapeutic doses of both timolol and amiodarone is blockade of:

Accepted Answer

Beta adrenoceptors

Answer

Cardiac Na+ channels

Answer

Cardiac K+ channels

Answer

Alpha-adrenoceptors

Question 9

Which of the following drugs acts as a Rho kinase inhibitor?

Accepted Answer

Fasudil

Answer

Trimetazidine

Answer

Pinacidil

Answer

Ranolazine

Question 10

What is the drug of choice for hypertensive emergency?

Accepted Answer

Intravenous Nicardipine

Answer

Intravenous Clevidipine

Answer

Intravenous Diltiazem

Answer

Intravenous Verapamil

Cardiovascular Drugs — MCQs

Cardiovascular Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?